Teladoc Health
TDOC
829 hedge funds and large institutions have $21.3B invested in Teladoc Health in 2021 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 334 increasing their positions, 287 reducing their positions, and 141 closing their positions.
16% more repeat investments, than reductions
Existing positions increased: 334 | Existing positions reduced: 287
3.27% more ownership
Funds ownership: 79.53% → 82.8% (+3.3%)
4% less capital invested
Capital invested by funds: $22.1B → $21.3B (-$778M)
7% less funds holding
Funds holding: 890 → 829 (-61)
18% less funds holding in top 10
Funds holding in top 10: 17 → 14 (-3)
38% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 141
42% less call options, than puts
Call options by funds: $1.86B | Put options by funds: $3.18B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$258M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$214M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$202M |
| 4 |
Morgan Stanley
New York
|
+$180M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$110M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCGM
General Catalyst Group Management
Cambridge,
Massachusetts
|
-$217M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$137M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$109M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$83.7M |
| 5 |
Jennison Associates
New York
|
-$74.2M |
TDOC Hedge Fund Activity: Q2 2021 in Review
829 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q2 2021, worth a combined $21.3B — down 3.5% from $22.1B a quarter earlier.
Sellers outnumbered buyers: 141 funds closed out of TDOC and 87 opened new positions — a net loss of 54 holders — while 287 trimmed existing stakes and 334 added.
The largest buyer was ARK Investment Management, adding an estimated $258M. The largest seller was General Catalyst Group Management, cutting an estimated $217M.
- 829 institutional investors held Teladoc Health (TDOC) as of Q2 2021, down from 890 in Q1 2021.
- Funds reported $21.3B of Teladoc Health stock for Q2 2021, down 3.5% quarter-over-quarter.
- 87 funds opened new Teladoc Health positions in Q2 2021 and 141 closed out, a net change of -54 holders.
- The largest Teladoc Health buyer in Q2 2021 was ARK Investment Management, an estimated $258M added.
- The largest Teladoc Health seller in Q2 2021 was General Catalyst Group Management, an estimated $217M sold.
Based on aggregated 13F filings for Q2 2021.